Skip to main content
. 2022 May 26;27:74. doi: 10.1186/s40001-022-00708-w

Table 2.

Patients’ and tumor characteristics among recipients with and without recurring hepatocellular carcinoma

Tumor recurrence (n = 20) Recurrence-free (n = 111) p
Age (years) 55 [29–64] 59 [34–70] 0.0255
Male gender (%) 65.0 78.4 0.2516
MELD score 10 [7–40] 11 [6–36] 0.3888
Etiology of liver disease 0.3226
 Alcohol (%) 15.0 26.1
 Hepatitis B (%) 30.0 12.6
 Hepatitis C (%) 35.0 43.3
 NASH (%) 10.0 10.8
 Other (%) 10.0 4.5
Within Milan criteria (%) 35.0 53.2 0.1522
AFP pre-treatment (U/mL) 101.3 [3.6–7454.0] 14.2 [1.0–13,923.0] 0.0036
Poor differentiation G3 (%) 25.0 8.1 0.0402
Microvascular invasion V1 (%) 45.0 4.5  < 0.0001
Complete necrosis (%) 5.0 52.3  < 0.0001